Epstein Secrets

e 3 of 6 -5227 Laboratory Director Printed 87/25/2016 07:01 g abed 4£9L886ZLZL LPsY AlleH Wd6E:g0 9LOZ 60 6w EFTA01733944 OSSOL000 1.8Thild3 BioReference LABORATORIES IIIII OIscm, HARRY HARRY FISCH, M.D. 944 PARK AVENUE New York, NY 10028 Acct It: (C1720-1) Si P: (212) 879-0800 herolysis. E

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

BioReference PRELIMINARY LABORATORIES D 0 T C R FISCH, HARRY C1720 - HARRY FISCH, M.D. NEW YORK, NY 10028 Acct #: (C1720) P: S1 L EPSTEIN, JEFFREY P

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

• miler g fir ;WAX Do. , ' EFTA00282982 M9 09 2016 0a37RI Harry Fitt' 12129881630 page 3 Q yavv?-7yryy ki-vvn ineyb vs>f EFTA00282983 BioReference LABORATORIES FINAL REPORT 0 0 L riscw, HARRY HARRY FISCH. M.D. New York, MY 10028 51 P: EPSTEIN, ]ErrRre D08:01/2%/1953 Age:63 Y Sex:PI

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

• miler g fir ;WAX Do. , ' EFTA00582642 M9 09 2016 0a37RI Harry Fitt' 12129881630 page 3 Q yavv?-7yryy ki-vvn ineyb vs>f EFTA00582643 BioReference <EPSTEIN, 1M08:01/23/1953 Address:3 ' NEW YOR‹. P: 2 ott at 'r$ `.r FINAL REPORT r ---,..,,,r LABORATORIES 0 Mai, HARRY .. 0 FARRY FIS

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate